Status:

UNKNOWN

Effect of BOSU Exercises Added to Complete Decongestive Treatment on Balance in Breast Cancer-associated Lymphedema.

Lead Sponsor:

Oya Topuz

Conditions:

Breast Cancer Related Lymphedema

Eligibility:

FEMALE

18-65 years

Phase:

NA

Brief Summary

The aim of the study is to investigate the effect of balance exercises performed with the BOSU ball added to complete decongestive treatment on static and dynamic balance in patients with breast cance...

Detailed Description

The study was planned as a randomized controlled study. The patients who had unilateral breast cancer-associated lymphedema according to the 2020 diagnostic criteria of the International Society of Ly...

Eligibility Criteria

Inclusion

  • Female gender
  • Patients aged 18-65 years
  • Having a history of unilateral mastectomy and lymph node dissection at least one year ago due to breast cancer diagnosis.
  • Having unilateral breast cancer-related upper extremity lymphedema (\>20% volume difference between the two upper extremities) according to the diagnostic criteria of the - International Society of Lymphology (Committee 2020) for at least six months.
  • Not having received lymphedema treatment or exercise therapy for the last six months
  • Completing breast cancer primary treatment at least 6 months ago (except hormone therapy/aromatase inhibitors)

Exclusion

  • Bilateral breast cancer
  • Bilateral axillary lymph node dissection
  • Metastatic breast cancer
  • Receiving ongoing radiotherapy or chemotherapy
  • Primary or bilateral lymphedema
  • Having active cancer
  • Presence of stage 3 lymphedema
  • Uncontrolled serious systemic disease (cardiopulmonary diseases, arterial or venous diseases, renal dysfunction, uncontrolled hypertension or hypotension).
  • Active or previous infection in the last 3 months (cellulitis, lymphangitis)
  • Presence of open wounds
  • Having any problems that may affect balance (vestibular, visual, neurological or orthopedic diseases)
  • Using medications that may affect body fluid and electrolyte balance (diuretics, etc.).
  • Individuals with serious mental and sensory problems
  • History of spine surgery in the last 6 months
  • Being pregnant
  • Body mass index \>40 kg/m2

Key Trial Info

Start Date :

January 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2025

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06182046

Start Date

January 1 2024

End Date

July 1 2025

Last Update

December 26 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.